Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 11/20 | 0.47 |
| ▸ | BACE1 | P56817 | 3/20 | 0.36 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.35 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.35 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.35 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.35 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.35 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 4/20 | 0.33 |
| ▸ | CTSS | P25774 | 4/20 | 0.33 |
| ▸ | CTSK | P43235 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9011705 | 0.82 | REN (0.50) | RENPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL7276185 | 0.71 | CTSL (0.52) | RENCTSLCTSSCTSK | |
| SCHEMBL23052492 | 0.65 | REN (0.44) | RENCTSLCTSSCTSK | |
| SCHEMBL7332409 | 0.65 | REN (0.51) | RENPSEN1PSEN2APH1BNCSTN | |
| SCHEMBL19270372 | 0.63 | MMP1 (0.51) | RENCTSLCTSSCTSK | |
| SCHEMBL7843875 | 0.62 | GRN (0.55) | RENCTSLCTSSCTSK | |
| SCHEMBL6467188 | 0.62 | GRN (0.55) | RENCTSLCTSSCTSK | |
| SCHEMBL29511128 | 0.62 | GRN (0.55) | RENCTSLCTSSCTSK | |
| SCHEMBL12506241 | 0.62 | CTSK (0.55) | RENCTSLCTSK | |
| SCHEMBL7212260 | 0.62 | REN (0.46) | RENPSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5545750-A | TREATING HUMAN IMMUNODEFICIENCY VIRUS | ABBOTT LABORATORIES (US) | 1996-08-13 | — | — | US | disclosed |
| US-5142056-A | Human immunodeficiency virus protease inhibitor | ABBOTT LABORATORIES (US) | 1992-08-25 | — | — | US | disclosed |